Expansion to triple production capacity at Wacker mRNA site in Germany 11-Jul-2022 By Jane Byrne Wacker Biotech’s site in Halle, Germany will be expanded in the coming months into a competence center for actives based on messenger ribonucleic acid (mRNA).
